Related Experiment Video
Updated: Feb 9, 2026

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
Pulmonary Artery Pseudoaneurysm: A Rare Cause of Fatal Massive Hemoptysis
Himaja Koneru1, Sreeja Biswas Roy2, Monirul Islam1
1Department of Thoracic Medicine, Geisinger Medical Center, Danville, PA, USA.
Abstract:
Pulmonary artery pseudoaneurysm (PAPA), an uncommon complication of pyogenic bacterial and fungal infections and related septic emboli, is associated with high mortality. The pulmonary artery (PA) lacks an adventitial wall; therefore, repeated endovascular seeding of the PA with septic emboli creates saccular dilations that are more likely to rupture than systemic arterial aneurysms. The most common clinical presentation of PAPA is massive hemoptysis and resultant worsening hypoxemia. Computed tomography angiography is the preferred diagnostic modality for PAPA; typical imaging patterns include focal outpouchings of contrast adjacent to a branch of the PA following the same contrast density as the PA in all phases of the study. In mycotic PAPAs, multiple synchronous lesions are often seen in segmental and subsegmental PAs due to ongoing embolic phenomena. The recommended approach for a mycotic PAPA is prolonged antimicrobial therapy; for massive hemoptysis, endovascular treatment (e.g., coil embolization, stenting, or embolization of the feeding vessel) is preferred. PAPA resection and lobectomy are a last resort, generally reserved for patients with uncontrolled hemoptysis or pleural hemorrhage. We present a case of a 28-year-old woman with necrotizing pneumonia from intravenous drug use who ultimately died from massive hemoptysis and shock after a ruptured PAPA.
Insights
Pulmonary artery pseudoaneurysms (PAPA) are rare, life-threatening infections of the pulmonary artery. Early diagnosis and endovascular treatment are crucial for managing this condition, especially in cases of hemoptysis.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Infectious Diseases
Background:
- Pulmonary artery pseudoaneurysm (PAPA) is an uncommon but high-mortality complication of infections and septic emboli.
- The pulmonary artery's lack of an adventitial wall predisposes it to rupture compared to systemic aneurysms.
Observation:
- PAPA commonly presents as massive hemoptysis and hypoxemia.
- Computed tomography angiography is the preferred diagnostic tool, revealing characteristic contrast-filled outpouchings.
- Mycotic PAPAs often present with multiple lesions due to ongoing embolic phenomena.
Findings:
- The case highlights a fatal outcome from a ruptured PAPA in a young woman with necrotizing pneumonia secondary to intravenous drug use.
- Endovascular treatment is preferred for hemoptysis, while prolonged antimicrobial therapy is recommended for mycotic PAPA.
- Surgical resection is a last resort for refractory cases.
Implications:
- This case underscores the critical need for prompt diagnosis and management of PAPA.
- Effective treatment strategies, including endovascular interventions, can improve patient outcomes.
- Understanding the pathophysiology is vital for preventing rupture and mortality in patients with PAPA.
More Related Videos
07:02A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep
Published on: July 15, 2021
10:03Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...